TRANSGENE BIOTEK

BSE: 526139 29 Jun 2025

Healthcare

₹ 4.3

Transgene Biotek Ltd. specializes in Healthcare Service Provider within the Healthcare sector.

TRANSGENE BIOTEK

BSE: 526139 29 Jun 2025

Healthcare

₹ 4.3

Transgene Biotek Ltd. specializes in Healthcare Service Provider within the Healthcare sector.

Book Value

-1.0

Dividend Yield

0.0%

Debt to Equity

Stock P/E

Market Cap

32.2 Cr

TRANSGENE BIOTEK - Share Price & Details

Market Cap

₹32.2

High /Low

10.8 / 3.22

Stock P/E

Book Value

₹-1.0

Dividend Yield

0.0

ROCE

-6.11

ROE

₹NA

Face Value

10.0

PEG Ratio

EVEBITDA

₹-137.0

Debt

14.5

CMP / FCF

-193.0

Debt to equity

₹NA

NP Ann

-0.68

High price all time

322.0

Piotroski score

₹4.0

Graham Number

No. Eq. Shares

7.58

Net CF

₹0.28

Net profit

-0.68

Price to book value

Interest Coverage

₹-1.79

Low price all time

1.55

Industry PE

50.6

Reserves

₹-83.3

Free Cash Flow

₹-0.50

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
TRANSGENE BIOTEK LTD.	NA	NA	NA	NA	32.2
Concord Drugs Limited	NA	NA	NA	NA	30.5	89.6
KK Shah Hospitals Limited	NA	NA	NA	NA	30.3

Peer Comparison Chart

About TRANSGENE BIOTEK

Transgene Biotek Ltd., with Security Code 526139, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Market ends with small gains amid rising Indo-Pak tensions

(20 May 2025)

Auto, consumer durables and realty shares advanced while FMCG and pharma shares corrected.

Q4 Results Highlights: United Breweries beats Street; Voltas profit doubles, EBIDTA up 75%

(08 May 2025)

Q4 Results Highlights: The fourth quarter earnings season is underway and as many as 16 important names like Coal India, Dabur India,...

Q4 Results Today: Coal India, MRF, Voltas, Dabur, PNB Among 50 Companies To Declare Earnings On May 7

(07 May 2025)

At least 50 companies are set to announce their results for the quarter and financial year ended March 31, 2025, on May 7.

Q4 Results Live Updates: Coal India, Dabur, Tata Chemicals among important earnings today

(07 May 2025)

Q4 Results Live Updates: Companies like Coal India, Dabur India, Tata Chemicals, United Breweries, Housing & Urban Development Corporation,...

Transgene Biotek reports consolidated net loss of Rs 0.71 crore in the March 2025 quarter

(07 May 2025)

Sales rise 60.00% to Rs 0.08 crore. Net Loss of Transgene Biotek reported to Rs 0.71 crore in the quarter ended March 2025 as against net loss of Rs 0.27...

Nifty May futures trade at premium

(07 May 2025)

Tata Motors, BSE and Punjab National Bank were the top traded contracts. The Nifty May 2025 futures closed at 24,472, a premium of 57.60...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2021	Dec 2021	Mar 2022	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.1	0.1
Expenses	2.6	0.2	0.1	22.0	0.2	0.2	0.3	0.5	0.1	0.2
Operating Profit	-2.6	-0.2	-0.1	-12.0	-0.1	-0.1	-0.3	-0.4	-0.1	-0.1
OPM %	-129450%	0%	-65.88%	-120.15%	-268.89%	-240%	-595.56%	-842.86%	-130.51%	-119.48%
Other Income	0.0	0.0	0.1	4.4	0.0	0.0	0.1	0.7	0.0	0.0
Interest	0.1	0.1	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	2.5	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	-2.6	-2.6	-2.5	-13.2	-0.1	-0.1	-0.3	0.2	-0.1	-0.1
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-2.6	-2.6	-2.5	-13.2	-0.1	-0.1	-0.3	0.2	-0.1	-0.1
EPS in Rs	-0.34	-0.35	-0.34	-0.02	-0.02	-0.02	-0.04	0.03	-0.01	-0.01

Metrics	Sep 2021	Dec 2021	Mar 2022	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	0.0	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.1	0.1
Expenses	2.6	0.2	0.1	22.7	0.2	0.2	0.3	0.5	0.1	0.2
Operating Profit	-2.6	-0.2	-0.1	-12.7	-0.1	-0.1	-0.3	-0.4	-0.1	-0.1
OPM %	-129500%	0%	-65.88%	-127.53%	-268.89%	-240%	-595.56%	-842.86%	-130.51%	-119.48%
Other Income	0.0	0.0	0.1	4.4	0.0	0.0	0.1	0.7	0.0	0.0
Interest	0.1	0.1	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	2.5	2.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0
Profit before tax	-2.6	-2.6	-2.5	-13.9	-0.1	-0.1	-0.3	0.2	-0.1	-0.1
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-2.6	-2.6	-2.5	-13.9	-0.1	-0.1	-0.3	0.2	-0.1	-0.1
EPS in Rs	-0.34	-0.35	-0.34	-0.02	0	-0.02	-0.04	0.03	-0.01	-0.01

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	-1%
5 Years:	0%
3 Years:	42%
TTM:	13%

Compounded Profit Growth
10 Years:	7%
5 Years:	14%
3 Years:	25%
TTM:	-3%

Stock Price CAGR
10 Years:	6%
5 Years:	5%
3 Years:	6%
1 Year:	-31%

Compounded Sales Growth
10 Years:	-1%
5 Years:	0%
3 Years:	42%
TTM:	13%

Compounded Profit Growth
10 Years:	7%
5 Years:	14%
3 Years:	25%
TTM:	-3%

Stock Price CAGR
10 Years:	6%
5 Years:	5%
3 Years:	6%
1 Year:	-31%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

TRANSGENE BIOTEK

TRANSGENE BIOTEK

TRANSGENE BIOTEK - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About TRANSGENE BIOTEK

Latest News

Market ends with small gains amid rising Indo-Pak tensions

Q4 Results Highlights: United Breweries beats Street; Voltas profit doubles, EBIDTA up 75%

Q4 Results Today: Coal India, MRF, Voltas, Dabur, PNB Among 50 Companies To Declare Earnings On May 7

Q4 Results Live Updates: Coal India, Dabur, Tata Chemicals among important earnings today

Transgene Biotek reports consolidated net loss of Rs 0.71 crore in the March 2025 quarter

Nifty May futures trade at premium

Vintage Coffee & Beverages consolidated net profit rises 263.72% in the March 2025 quarter

Q4 Results 2025 This Week: Paytm, Coal India, Asian Paints, L&T, Swiggy Among 280+ Firms To Declare Earnings

Q4 results: Coal India, PNB, Dabur, MRF, Voltas, HUDCO, Tata Chemicals, others to declare earnings on May 7; check list

NSE Q4 profit up 7% YoY, down 31% sequentially; declares Rs 35 dividend

Analyzing The Growth Of The Oncolytic Virus Immunotherapy Market: From USD 32.8 Billion To USD 399 Billion By 2035

Q3 Results Today: IndiGo, DLF, JSW Steel, Shakti Pumps Among 80 Companies To Announce Quarterly Earnings

Q3 results: IndiGo, JSW Steel, Shriram Finance, DLF, Godrej Consumer, others to announce earnings on Jan 24; check list

Q3 results today: Indigo, JSW Steel, AU Small Finance Bank & others to declare earnings on January 24

Sensex falls! These stocks fell 5% or more in Friday's session

Stock Market Highlights: Sensex ends at 78,139, signs-off 2024 with 8% gain; Nifty holds 23,600

Oncolytic Virus Immunotherapy Market Size Expected to Hit USD 615.39 Million by 2032, Expanding at a 25.5%

SIL Investments consolidated net profit rises 26.69% in the September 2024 quarter

Hyundai Motor India, P N Gadgil Jewellers Among 500+ Companies To Declare Q2 Results Today

Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter

Oral insulin spray in a few years, says Hyderabad firm

Q1 results today: Aurobindo Pharma, APL Apollo Tubes, Finolex Cables, others to post earnings on August 10; check list

Transgene Biote Consolidated June 2024 Net Sales at Rs 0.05 crore, down 50.75% Y-o-Y

Transgene Biote Standalone June 2024 Net Sales at Rs 0.05 crore, down 50.75% Y-o-Y

Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter

MIDHANI slides as Q1 PAT drops 72% YoY

Q1 Results Today: Aurobindo Pharma, APL Apollo Tubes, Finolex Cables among 137 companies to post earnings on August 10

Oncolytic Virus Immunotherapy Market Opportunities, Growth Analysis And Forecast 2024-2032

Watch out for these Penny Stocks locked in the upper circuit on June 11

Q4 Results Today: Reliance Infra, Muthoot Finance, Apollo Hospitals among 908 companies to post earnings on May 30 | Company Business News

Q4 Results Today: Reliance Infra, Muthoot Finance, Apollo Hospitals among 908 companies to post earnings on May 30

Deccan Health Care Share Price

Tejnaksh Healthcare Share Price

Transgene Biotek reports consolidated net loss of Rs 1.39 crore in the June 2022 quarter

Transgene and NEC Continue Joint Development of Neoantigen Cancer Vaccine TG4050: Press Releases

Unitech to GG Engineering: These 10 penny stocks gave up to 150% in November 2023 | Stock Market News

Unitech to GG Engineering: These 10 penny stocks gave up to 150% in November 2023

Top-performing penny stocks; 3 Companies Doubled in Value, 2 Generated 10-fold Returns

NiedlFree Tech brings oral insulin

Penny Stock Under Rs 5: Don't Miss Out on the Micro-Cap's Major News!

NiedlFree Technologies revolutionises diabetes treatment by replacing injections with sprays

Hyderabad company introduces nasal insulin for diabetic patients

Oral insulin spray may replace injectable insulin by 2025, thanks to a Hyderabad-based pharma company

Hyderabad company makes nasal insulin spray for diabetic patients

No more painful insulin shots: Hyderabad company develops oral insulin spray for diabetes

Insulin shot painful? Hyderabad company may roll out oral spray in few yrs

AstraZeneca scraps pact with Riva-led Transgene in further blow to oncolytic viruses

Transgene Biotek reports consolidated net loss of Rs 1.38 crore in the December 2022 quarter

Transgene Biotek Ltd Share Price Today, Stock Price BSE

Transgene Biotek Ltd Share Price Today, null Share Price NSE, BSE

Transgene Biotek Share Price Today - Transgene Biotek Stock Price Live NSE/BSE

Transgene Biotek Ltd -Got Certificate Of Patent From Australia For Oral Delivery Platform Technology

BRIEF-India's Transgene Biotek Accepts Resignation Of Vikram Polavarapu As MD By Reuters

GDR case: Sebi bars Transgene Biotek, 6 others from securities mkt

GDR issue: SEBI lifts market ban on Transgene Biotek’s 2 promoters, director

Sure shot performers! Top 6 stocks which rose up to 140% in June quarter in 5 years

As SEBI sleeps, Transgene Biotek hits upper and lower circuit on same day!

BRIEF-Transgene Biotek to initiate modalities of setting up unit By Reuters

Transgene alleges $38 million fraud by Nirmal Kotecha, aides

SEBI bans Transgene for diverting GDR proceeds

Transgene Biotek stock to be delisted in India

India's Transgene Biotek claims early success in oral insulin for rats

Quarterly Table

Shareholding Distribution

Shareholding Pattern

Compounded Data

All Deals

Select Date

Stock Mutual Funds Data